Catalyst Pharmaceuticals, Inc.
CPRXDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001369568
Catalyst Pharmaceuticals, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 395 institutions reported holding it in 13F filings for Q2 2026, worth $3.39B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Catalyst Pharmaceuticals, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 316
- +47 vs. Q2 2024
- Shares held
- 95.5M
- +17.3M (+22.1%) vs. Q2 2024
- Total value
- $1.90B
- +$687.6M (+56.7%) vs. Q2 2024
- New holders
- 68
- 97 more added
- Sold out
- 21
- 105 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CPRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 395 | $3.39B |
| Q1 2026 | 382 | $2.59B |
| Q4 2025 | 375 | $2.43B |
| Q3 2025 | 360 | $2.04B |
| Q2 2025 | 365 | $2.20B |
| Q1 2025 | 370 | $2.37B |
| Q4 2024 | 336 | $2.04B |
| Q3 2024 | 316 | $1.90B |
| Q2 2024 | 271 | $1.50B |
| Q1 2024 | 268 | $1.53B |
| Q4 2023 | 259 | $1.42B |
| Q3 2023 | 256 | $948.8M |
| Q2 2023 | 248 | $1.11B |
| Q1 2023 | 260 | $1.47B |
| Q4 2022 | 257 | $1.56B |
| Q3 2022 | 229 | $1.09B |
| Q2 2022 | 190 | $531.7M |
| Q1 2022 | 186 | $585.5M |
| Q4 2021 | 164 | $446.7M |
| Q3 2021 | 144 | $345.1M |
| Q2 2021 | 139 | $376.6M |
| Q1 2021 | 133 | $312.0M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Catalyst Pharmaceuticals, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Charles Schwab Investment Management Inc | 1,167,743 | $23.2M | 0.00% | +50,804+4.5% | Added |
| Price T Rowe Associates Inc | 1,234,383 | $24.5M | 0.00% | +1,531+0.1% | Added |
| Boston Partners | 1,275,267 | $25.6M | 0.03% | −131,113−9.3% | Reduced |
| Northern Trust Corp | 1,383,800 | $27.5M | 0.00% | −2,907−0.2% | Reduced |
| Goldman Sachs Group Inc | 1,472,253 | $29.3M | 0.01% | +384,122+35.3% | Added |
| Morgan Stanley | 1,823,274 | $36.2M | 0.00% | +810,595+80.0% | Added |
| Royce & Associates LP | 2,021,105 | $40.2M | 0.37% | −140,917−6.5% | Reduced |
| First Trust Advisors LP | 2,428,973 | $48.3M | 0.05% | −43,960−1.8% | Reduced |
| Renaissance Technologies LLC | 2,526,016 | $50.2M | 0.08% | +350,289+16.1% | Added |
| Geode Capital Management, LLC | 2,664,424 | $53.0M | 0.00% | −34,189−1.3% | Reduced |
| Pacer Advisors, Inc. | 2,804,013 | $55.7M | 0.12% | −163,562−5.5% | Reduced |
| Dimensional Fund Advisors LP | 3,018,789 | $60.0M | 0.01% | +18,033+0.6% | Added |
| State Street Corp | 5,685,330 | $113.0M | 0.00% | −347,968−5.8% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 6,229,634 | $123.8M | 1.85% | −2,897,671−31.7% | Reduced |
| Vanguard Group Inc | 8,040,978 | $159.9M | 0.00% | −59,377−0.7% | Reduced |
| BlackRock, Inc. | 19,017,491 | $378.1M | 0.01% | +19,017,491 | New |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −618,296−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −288,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −51,815−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −40,174−100.0% | Sold out |
| UniSuper Management Pty Ltd | 0 | $0 | 0.00% | −28,265−100.0% | Sold out |
| Gallacher Capital Management LLC | 0 | $0 | 0.00% | −18,564−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −16,334−100.0% | Sold out |
| Sumitomo Mitsui Trust Holdings, Inc. | 0 | $0 | 0.00% | −14,800−100.0% | Sold out |
| Strategic Advocates LLC | 0 | $0 | 0.00% | −14,142−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −12,128−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −11,845−100.0% | Sold out |
| PVG Asset Management Corp | 0 | $0 | 0.00% | −11,786−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −11,266−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −10,609−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −10,200−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −9,857−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −8,523−100.0% | Sold out |
| New Vernon Capital Holdings II LLC | 0 | $0 | 0.00% | −7,864−100.0% | Sold out |
| Innealta Capital, LLC | 0 | $0 | 0.00% | −162−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Aspire Private Capital, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |